Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of CC-4047 Plus Dexamethasone in Patients With Relapsed of Refractory Multiple Myeloma or Amyloidosis

NCT00558896 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00558896
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00558896 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of CC-4047 Plus Dexamethasone in Patients With Relapsed of Refractory Multiple Myeloma or Amyloidosis
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2007
Completion date
October 25, 2017
Enrollment
378 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma and plasma cell neoplasm